EGFR fluorescence in situ hybridisation assay: guidelines for application to non-small-cell lung cancer

There is a need for predictive biomarkers that identify non-small-cell lung cancer (NSCLC) patients most likely to respond to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) treatment. There are numerous potential candidates, although none has been proven in prospective clini...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Varella-Garcia, M, Diebold, J, Eberhard, D A, Geenen, K, Hirschmann, A, Kockx, M, Nagelmeier, I, Rüschoff, J, Schmitt, M, Arbogast, S, Cappuzzo, F
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Group 2009
Assuntos:
Reviews
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2771853/
https://ncbi.nlm.nih.gov/pubmed/19861557
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jcp.2009.066548
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados